HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weiping Qin Selected Research

Anabolic Androgenic Steroids

1/2015Anabolic steroids activate calcineurin-NFAT signaling and thereby increase myotube size and reduce denervation atrophy.
11/2013Anabolic steroids reduce spinal cord injury-related bone loss in rats associated with increased Wnt signaling.
11/2012Nandrolone, an anabolic steroid, stabilizes Numb protein through inhibition of mdm2 in C2C12 myoblasts.
10/2011Nandrolone reduces activation of Notch signaling in denervated muscle associated with increased Numb expression.
10/2010Differential alterations in gene expression profiles contribute to time-dependent effects of nandrolone to prevent denervation atrophy.
3/2010Nandrolone slows hindlimb bone loss in a rat model of bone loss due to denervation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Weiping Qin Research Topics

Disease

10Alzheimer Disease (Alzheimer's Disease)
03/2009 - 12/2003
9Muscular Atrophy (Muscle Atrophy)
01/2021 - 01/2009
8Spinal Cord Injuries (Spinal Cord Injury)
01/2021 - 03/2010
4Neoplasms (Cancer)
08/2018 - 02/2016
4Atrophy
01/2015 - 10/2010
4Amyloidosis
12/2008 - 12/2003
3Dementia (Dementias)
03/2009 - 12/2005
3Amyloid Plaque
03/2009 - 04/2005
2Hypertrophy
01/2017 - 01/2015
2Adenocarcinoma
02/2016 - 03/2015
2Diabetes Mellitus
12/2005 - 05/2004
2Insulin Resistance
12/2005 - 05/2004
1Bone Resorption
03/2020
1Osteoporosis
10/2018
1Hyperglycemia
01/2018
1Inflammation (Inflammations)
01/2017
1Wounds and Injuries (Trauma)
01/2016
1Paralysis (Palsy)
01/2015
1Poisoning
06/2014
1Sarcopenia
10/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2007
1Cognitive Dysfunction
01/2006
1Disease Progression
12/2005
1Fibrosis (Cirrhosis)
12/2005
1Type 2 Diabetes Mellitus (MODY)
05/2004

Drug/Important Bio-Agent (IBA)

8Amyloid beta-PeptidesIBA
03/2009 - 12/2003
6Anabolic Androgenic SteroidsIBA
01/2015 - 03/2010
5Nandrolone (Nortestosterone)IBA
01/2015 - 03/2010
5Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2009 - 12/2003
4Proteins (Proteins, Gene)FDA Link
01/2016 - 03/2009
4Amyloid (Amyloid Fibrils)IBA
03/2009 - 12/2005
4Peptides (Polypeptides)IBA
01/2009 - 12/2003
3Pharmaceutical PreparationsIBA
01/2018 - 01/2006
3PolymersIBA
11/2017 - 03/2015
3Insulin (Novolin)FDA Link
01/2016 - 05/2004
3GlucocorticoidsIBA
07/2014 - 03/2010
2Messenger RNA (mRNA)IBA
01/2021 - 03/2009
2Therapeutic UsesIBA
01/2018 - 01/2006
2MyostatinIBA
01/2017 - 01/2016
2salicylhydroxamic acid (SHAM)IBA
01/2016 - 01/2016
2AndrogensIBA
01/2015 - 10/2011
2Muscle Proteins (Muscle Protein)IBA
07/2014 - 12/2010
2Ligases (Synthetase)IBA
12/2010 - 01/2009
2UbiquitinIBA
12/2010 - 01/2009
2Testosterone (Sustanon)FDA Link
12/2010 - 03/2010
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2006 - 12/2003
1MethylprednisoloneFDA LinkGeneric
01/2021
1Aligeron (AS 2)IBA
03/2020
1Cell-Penetrating PeptidesIBA
08/2018
1CarbonIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Free RadicalsIBA
11/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017
1MyokinesIBA
01/2017
1Singlet OxygenIBA
02/2016
1Activins (Activin)IBA
01/2016
1MicroRNAs (MicroRNA)IBA
01/2016
1Activin Receptors (Activin Receptor)IBA
01/2016
1Testosterone CongenersIBA
01/2015
1CalcineurinIBA
01/2015
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2015
1Calcineurin InhibitorsIBA
01/2015
1Transcription Factors (Transcription Factor)IBA
07/2014
1HydrogenIBA
06/2014
1CalciumIBA
08/2013
1Notch ReceptorsIBA
11/2012
1p38 Mitogen-Activated Protein KinasesIBA
12/2010
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2010
1PPAR gammaIBA
03/2009
1Complementary DNA (cDNA)IBA
03/2009
1MetalsIBA
01/2009
1Biomarkers (Surrogate Marker)IBA
01/2009
1Carrier Proteins (Binding Protein)IBA
01/2009
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
12/2008
1CarbohydratesIBA
01/2007
1NAD (NADH)IBA
08/2006
1Sirtuin 1IBA
08/2006
1SirtuinsIBA
08/2006
1Cyclooxygenase InhibitorsIBA
01/2006
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2006
1Connective Tissue Growth FactorIBA
12/2005
1Biological ProductsIBA
12/2005
1Insulin ReceptorIBA
05/2004
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
05/2004
1Insulysin (Insulin-Degrading Enzyme)IBA
05/2004
1Protein Kinases (Protein Kinase)IBA
05/2004
1Phosphatidylinositols (Phosphatidylinositol)IBA
05/2004
1Protein Isoforms (Isoforms)IBA
12/2003

Therapy/Procedure

5Denervation
01/2015 - 03/2010
4Therapeutics
10/2018 - 02/2016
2Precision Medicine
01/2018 - 11/2017
2Lasers (Laser)
01/2018 - 01/2009
2Semiconductors
02/2016 - 03/2015
1Intravenous Injections
01/2021
1Laminectomy
10/2018
1Nanospheres
01/2018
1Stem Cell Transplantation
01/2017
1Photochemotherapy (Photodynamic Therapy)
02/2016
1Diet Therapy (Therapy, Diet)
01/2007
1Caloric Restriction
04/2005